Loading...
RPID logo

Rapid Micro Biosystems, Inc.NasdaqCM:RPID Stock Report

Market Cap US$185.7m
Share Price
US$4.19
n/a
1Y301.0%
7D0.5%
Portfolio Value
​
View

Rapid Micro Biosystems, Inc.

NasdaqCM:RPID Stock Report

Market Cap: US$185.7m

Rapid Micro Biosystems (RPID) Stock Overview

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. More details

RPID fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Revenue is forecast to grow 20.32% per year

Earnings have grown 8.4% per year over the past 5 years

Risk Analysis

Currently unprofitable and not forecast to become profitable over the next 3 years

Volatile share price over the past 3 months compared to the US market


RPID Community Fair Values

Create Narrative

See what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.

RPID logo
Rapid Micro Biosystems

Global Automation And Regulatory Emphasis Will Drive Pharmaceutical Modernization

Key Takeaways Rising demand for automated, data-driven microbiology QC and regulatory shifts supports strong system placements and recurring consumables revenue, strengthening growth and margins. Strategic partnerships and operational efficiencies drive expanded commercial reach, cost leverage, and improve financial stability through recurring revenues and margin expansion.
View narrative
US$8
FV
47.6% undervalued intrinsic discount
17.27%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
View Stock Community

Rapid Micro Biosystems, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Rapid Micro Biosystems
Historical stock prices
Current Share PriceUS$4.19
52 Week HighUS$4.50
52 Week LowUS$0.87
Beta1.38
1 Month Change40.13%
3 Month Change73.86%
1 Year Change300.96%
3 Year Change127.72%
5 Year Changen/a
Change since IPO-80.42%

Recent News & Updates

Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 37% Jump Shows Its Popularity With Investors

Nov 14
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 37% Jump Shows Its Popularity With Investors

Recent updates

Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 37% Jump Shows Its Popularity With Investors

Nov 14
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 37% Jump Shows Its Popularity With Investors

We Think Rapid Micro Biosystems (NASDAQ:RPID) Needs To Drive Business Growth Carefully

Jul 23
We Think Rapid Micro Biosystems (NASDAQ:RPID) Needs To Drive Business Growth Carefully

Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'

Jul 22

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stocks Shoot Up 45% But Its P/S Still Looks Reasonable

May 27
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stocks Shoot Up 45% But Its P/S Still Looks Reasonable

We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Apr 21
We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate
User avatar

MilliporeSigma And Lonza Collaborations Will Expand Market Reach

The global agreement with MilliporeSigma is set to expand Growth Direct's market reach and potentially enhance supply chain efficiency, boosting future revenues.

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 05
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Just Reported And Analysts Have Been Lifting Their Price Targets

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Looks Just Right With A 70% Price Jump

Mar 02
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Looks Just Right With A 70% Price Jump

Investors Still Aren't Entirely Convinced By Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Revenues Despite 27% Price Jump

Jan 16
Investors Still Aren't Entirely Convinced By Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Revenues Despite 27% Price Jump

Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story

Nov 02
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story

Is Rapid Micro Biosystems (NASDAQ:RPID) In A Good Position To Invest In Growth?

Oct 29
Is Rapid Micro Biosystems (NASDAQ:RPID) In A Good Position To Invest In Growth?

A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb

Aug 03
A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb

We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Jun 30
We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Rapid Micro to introduce RMBNucleus software for mold detection in pharma manufacturing

Oct 10

Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth

May 09
Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth

Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67

Mar 08
Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67

We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Feb 07
We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Shareholder Returns

RPIDUS Life SciencesUS Market
7D0.5%1.8%4.1%
1Y301.0%2.8%12.6%

Return vs Industry: RPID exceeded the US Life Sciences industry which returned 2.8% over the past year.

Return vs Market: RPID exceeded the US Market which returned 12.6% over the past year.

Price Volatility

Is RPID's price volatile compared to industry and market?
RPID volatility
RPID Average Weekly Movement12.0%
Life Sciences Industry Average Movement8.9%
Market Average Movement6.5%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market3.0%

Stable Share Price: RPID's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: RPID's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2006163Rob Spignesiwww.rapidmicrobio.com

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables.

Rapid Micro Biosystems, Inc. Fundamentals Summary

How do Rapid Micro Biosystems's earnings and revenue compare to its market cap?
RPID fundamental statistics
Market capUS$185.71m
Earnings (TTM)-US$44.29m
Revenue (TTM)US$30.52m
6.1x
P/S Ratio
-4.2x
P/E Ratio

Is RPID overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RPID income statement (TTM)
RevenueUS$30.52m
Cost of RevenueUS$28.17m
Gross ProfitUS$2.36m
Other ExpensesUS$46.65m
Earnings-US$44.29m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-1.00
Gross Margin7.72%
Net Profit Margin-145.11%
Debt/Equity Ratio0%

How did RPID perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/30 07:47
End of Day Share Price 2025/11/28 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rapid Micro Biosystems, Inc. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tycho PetersonJ.P. Morgan
Paul KnightKeyBanc Capital Markets Inc.
Thomas FlatenLake Street Capital Markets, LLC